Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Not applicableEnrolling By InvitationNCT00068003What this trial is testingHarvesting Cells for Experimental Cancer TreatmentsWho this might be right forMelanomaGastrointestinal CancerMetastatic Cancer+2 more National Cancer Institute (NCI) 7,000
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Early research (Phase 1)Study completedNCT02096614What this trial is testingInvestigator Initiated Phase 1 Study of TBI-1201Who this might be right forSolid Tumors Mie University 18
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 450
Testing effectiveness (Phase 2)Study completedNCT01177397What this trial is testingStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forMultiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more Celgene 226
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Testing effectiveness (Phase 2)Ended earlyNCT05568017What this trial is testingNeoadjuvant PRRT With Y-90-DOTATOC in pNETWho this might be right forPancreatic Neuroendocrine Tumor European Institute of Oncology 11
Early research (Phase 1)Study completedNCT00942682What this trial is testingSorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor Dana-Farber Cancer Institute 21
Early research (Phase 1)Active Not RecruitingNCT05902520What this trial is testingAdoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsWho this might be right forHNSCCMelanomaGynecologic Cancer+3 more AgonOx, Inc. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05275374What this trial is testingXP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 MutationWho this might be right forCancerBRAF V600 MutationMelanoma+3 more Xynomic Pharmaceuticals, Inc. 221
Not applicableStudy completedNCT01658917What this trial is testingCollecting Solid Tumor Tissue to Identify New TreatmentsWho this might be right forGastrointestinal CancerLiver CancerPancreatic Cancer+1 more National Cancer Institute (NCI) 133
Testing effectiveness (Phase 2)Looking for participantsNCT04268121What this trial is testingEfficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine CarcinomasWho this might be right forNeuroendocrine CarcinomaDigestive Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 78
Testing effectiveness (Phase 2)UnknownNCT03638206What this trial is testingAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesWho this might be right forB-cell Acute Lymphoblastic LeukemiaLymphomaMyeloid Leukemia+13 more Shenzhen BinDeBio Ltd. 73
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Not applicableStudy completedNCT01528774What this trial is testingCulture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersWho this might be right forMelanoma Wolfram Samlowski 150
Early research (Phase 1)Study completedNCT01390818What this trial is testingTrial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic Solid TumorBreast Cancer+3 more EMD Serono 146
Not applicableLooking for participantsNCT06141369What this trial is testingTreatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)Who this might be right forAdrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Ended earlyNCT04032704What this trial is testingLadiratuzumab Vedotin in Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more Seagen Inc. 205
Early research (Phase 1)Ended earlyNCT06052852What this trial is testingStudy of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesWho this might be right forTriple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more Bolt Biotherapeutics, Inc. 17